Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 13 07 2022
revised: 13 10 2022
accepted: 19 10 2022
pubmed: 29 10 2022
medline: 15 12 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

A high body mass index (BMI) is often associated with metabolic syndrome, which is accompanied by systemic low-grade chronic inflammation. Here, we analyzed whether BMI, other components of metabolic syndrome, and/or inflammatory markers correlate with left ventricular geometry, function, and infarct size as assessed by serial cardiac magnetic resonance imaging (MRI) after a first (clinically evident) ST-elevation MI (STEMI). Within the Etiology, Titre-Course, and effect on Survival (ETiCS) study, cardiac MRI conducted 7-9 days and 12 months after MI enabled longitudinal characterization of patients with a first STEMI along with serial routine blood counts and multiplex cytokine measurements. Of 91 locally included STEMI patients, 47% were overweight (25 kg/m Both BMI and HbA1c correlated negatively with LVEF only early, but not late after STEMI. Peak CRP evolved as strongest predictor of cardiac function at all time points independent of the metabolic syndrome.

Sections du résumé

BACKGROUND
A high body mass index (BMI) is often associated with metabolic syndrome, which is accompanied by systemic low-grade chronic inflammation. Here, we analyzed whether BMI, other components of metabolic syndrome, and/or inflammatory markers correlate with left ventricular geometry, function, and infarct size as assessed by serial cardiac magnetic resonance imaging (MRI) after a first (clinically evident) ST-elevation MI (STEMI).
METHODS
Within the Etiology, Titre-Course, and effect on Survival (ETiCS) study, cardiac MRI conducted 7-9 days and 12 months after MI enabled longitudinal characterization of patients with a first STEMI along with serial routine blood counts and multiplex cytokine measurements.
RESULTS
Of 91 locally included STEMI patients, 47% were overweight (25 kg/m
CONCLUSION
Both BMI and HbA1c correlated negatively with LVEF only early, but not late after STEMI. Peak CRP evolved as strongest predictor of cardiac function at all time points independent of the metabolic syndrome.

Identifiants

pubmed: 36306955
pii: S0167-5273(22)01653-9
doi: 10.1016/j.ijcard.2022.10.142
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-50

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have no conflicts of interest to declare. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

Auteurs

Jan Traub (J)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany; Interdisciplinary Center for Clinical Research, University Würzburg, Germany. Electronic address: traub_j1@ukw.de.

Paula Schürmann (P)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany.

Dominik Schmitt (D)

Department of Internal Medicine I, University Hospital Würzburg, Germany.

Tobias Gassenmaier (T)

Department of Diagnostic and Interventional Radiology, University Hospital Würzburg, Germany.

Georg Fette (G)

Data Integration Center, University Hospital Würzburg, Germany.

Stefan Frantz (S)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany.

Stefan Störk (S)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany.

Niklas Beyersdorf (N)

Institute for Virology and Immunobiology, University of Würzburg, Germany.

Valérie Boivin-Jahns (V)

Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany; Department of Pharmacology and Toxicology, University of Würzburg, Germany.

Roland Jahns (R)

Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany; Interdisciplinary Bank of Biomaterials and Data Würzburg, University Hospital and University Würzburg, Germany.

Ulrich Hofmann (U)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany.

Anna Frey (A)

Department of Internal Medicine I, University Hospital Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH